Clinical Trial

ProspEXPO : Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOsome

Study acronym: ProspEXPO
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to build up a bio-collection of biological samples from patients with cirrhosis. Further work using this bio-collection will permit to describe the influence of different exposome factors (nutrition, physical activity, socio-demographic conditions, tobacco, alcohol, pollutants) on the occurrence of the main type of liver cancer (called HCC). Indeed, in the vast majority of cases, HCC develops within cirrhosis, and the factors that precipitate the progression of cirrhotic patients to HCC remain largely unknown.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-05.
Status change: Not Yet Recruiting → Recruiting 2026-06-09
Trial Details
NCT Number NCT07119957
Lead Sponsor University Hospital, Angers
Conditions Cirrhoses, Liver, Carcinoma Liver
Enrollment 300 participants
Start Date 2025-12-17
Primary Completion 2028-12 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-10